UBS raises Legend Biotech stock price target on NHL therapy outlook

Markets Investing.com By Investing.com 03 Jun 2026 11:37 1 min read

UBS raises Legend Biotech stock price target on NHL therapy outlook

UBS raises Legend Biotech stock price target on NHL therapy outlook

UBS raises Legend Biotech stock price target on NHL therapy outlook

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.